ITGA2B Gene Thrombocytopenia Neonatal Alloimmune Genetic Test
Welcome to DNA Labs UAE, a leading genetic lab offering comprehensive genetic testing services. In this blog, we will discuss the ITGA2B Gene Thrombocytopenia Neonatal Alloimmune Genetic Test, including its cost, symptoms, diagnosis, and other important details.
Test Name: ITGA2B Gene Thrombocytopenia Neonatal Alloimmune Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Hematology
Doctor: Hematologist
Test Department: Genetics
Pre Test Information
Before undergoing the ITGA2B Gene Thrombocytopenia Neonatal Alloimmune Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by ITGA2B Gene Thrombocytopenia Neonatal Alloimmune NGS Genetic DNA Test gene ITGA2B.
Test Details
The ITGA2B gene is responsible for encoding a protein called integrin alpha-IIb, which is found on the surface of platelets. Thrombocytopenia is a condition characterized by a low platelet count, leading to abnormal bleeding and bruising. Neonatal alloimmune thrombocytopenia (NAIT) is a specific type of thrombocytopenia that occurs in newborn babies due to an immune response against platelets.
In NAIT, the mother produces antibodies against the father’s platelets, which can cross the placenta and attack the baby’s platelets. This can result in severe bleeding and other complications in the newborn.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. In the context of thrombocytopenia and NAIT, NGS genetic testing can identify genetic variants or mutations in the ITGA2B gene or other relevant genes associated with these conditions.
This test can aid in the diagnosis and management of thrombocytopenia and NAIT, as well as provide information about the risk of recurrence in future pregnancies.
For more information or to schedule an appointment for the ITGA2B Gene Thrombocytopenia Neonatal Alloimmune Genetic Test, please contact our Genetics Test Department.
Test Name | ITGA2B Gene Thrombocytopenia neonatal alloimmune Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hematology |
Doctor | Hematologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ITGA2B Gene Thrombocytopenia, neonatal alloimmune NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ITGA2B Gene Thrombocytopenia, neonatal alloimmune NGS Genetic DNA Test gene ITGA2B |
Test Details |
The ITGA2B gene is responsible for encoding a protein called integrin alpha-IIb, which is found on the surface of platelets. Thrombocytopenia is a condition characterized by a low platelet count, which can result in abnormal bleeding and bruising. Neonatal alloimmune thrombocytopenia (NAIT) is a specific type of thrombocytopenia that occurs in newborn babies due to an immune response against platelets. In NAIT, the mother produces antibodies against the father’s platelets, which can then cross the placenta and attack the baby’s platelets. This can lead to severe bleeding and other complications in the newborn. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. In the context of thrombocytopenia and NAIT, NGS genetic testing can be used to identify genetic variants or mutations in the ITGA2B gene or other relevant genes that may be associated with these conditions. This can help in the diagnosis and management of thrombocytopenia and NAIT, as well as provide information about the risk of recurrence in future pregnancies. |